Generate report
Zpd A/S
H E Bluhmes Vej 63, 6700 Esbjerg, CVR 32834825
ad
More financial key figures and analyses?
In Bisbase Premium you get more financial key figures for both companies, groups and industries plus access to exclusive industries complied by experts. You can also create your own analyses! It only takes a minute or so - and it's free!
Rank Profit for the year
Rank in industry
4/33
"Top 35%"
Rank in Denmark
17,510/336,950
"Top 10%"
Top management top 3
| Frank Marek 1 | CEO |
| Hiroyuki Shinya 1 | Director |
Board top 3
| Masakazu Sakurai 1 | Chairman of board |
| Frank Marek 1 | Boardmember |
| Mitsuru Iwai 1 | Boardmember |
Legal owners top 3
Rights certificate
Selskabet tegnes af to bestyrelsesmedlemmer i forening, af et bestyrelsesmedlem i forening med en direktør eller af den samlede bestyrelse.
Company information based on CVR
| Name | Zpd A/S |
| Alternate names | Biofac Esbjerg A/S, Zeria Denmark A/S, Zeria Pharma Denmark A/S, Zeria Pharmaceutical Denmark A/S, Zp Denmark A/S Show more |
| CVR | 32834825 |
| Address | H E Bluhmes Vej 63, 6700 Esbjerg |
| Industry | Manufacture of basic pharmaceutical products [211000] |
| Established | 04-03-2010 (13 yr) |
| First financial statement period | 01-07-2009 to 30-06-2010 |
| Company type | Limited Corporation |
| Number of employees | 38 (man years:34) |
| Advertising protection | No |
| Auditor | Ey Godkendt Revisionspartnerselskab since 16-09-2010 |
| Financial statement period | 01-01 to 31-12 |
| Company capital | 1,000,000 DKK |
| Articles of assoc. last | 14-01-2015 |
Member of industries
- Manufacture of basic pharmaceutical productsNACE6 containing 38 comp.
- Manufacture of basic pharmaceutical productsNACE3 containing 38 comp.
- Manufacture of basic pharmaceutical products and pharmaceutical preparationsNACE2 containing 254 comp.
- ManufacturingNACE1 containing 26,560 comp.
Purpose
Selskabets formål er at drive fabrikation og handel med kemiske produkter.
Financial Statement
| 2022 | 2021 | 2020 | |
|---|---|---|---|
| Currency/unit | 000' DKK | 000' DKK | 000' DKK |
| Revenue | - - | - - | - - |
| Gross Profit | 37,256 +6% | 35,200 -1% | 35,568 -3% |
| Profit for the year | 7,067 +1% | 6,963 +17% | 5,954 -23% |
| Equity | 185,232 +4% | 178,166 +4% | 171,203 +4% |
| Total Assets | 197,014 +4% | 189,620 +4% | 182,960 +5% |
Mangement review
The income statement for 2022 shows a profit of DKK 7,067 thousand against a profit of DKK 6,963 last year, and the balance sheet at 31 December 2022 shows equity of DKK 185,232 thousand. In the annual report for 2021 Management expected a profit for 2022 on the same level as 2021. Management considers the Company's financial performance in the year satisfactory.
22-03-2023